The hsv testing market is projected to grow from USD 640.5 million in 2025 to USD 1,142.7 million by 2035, at a CAGR of 6.0%. HSV-1/HSV-2 Combines will dominate with a 49.0% market share, while serological tests will lead the test type outlook segment with a 49.8% share.